New Alzheimer's drug candidate J4 enters first human safety tests
NCT ID NCT06938763
First seen Jan 08, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This early-stage trial tests whether a new drug called J4 is safe for people. It is given as a dry powder capsule by mouth. The study involves 76 healthy adults aged 18 to 64. Researchers will monitor side effects and how the drug moves through the body. This is a first step before testing the drug in people with Alzheimer's disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Taipei Medical University Hospital
RECRUITINGTaipei, 110, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.